Responses
Regular and young investigator award abstracts
Clinical trials in progress
352 Updated clinical data from the squamous cell carcinoma of the head and neck (SCCHN) expansion cohort of an ongoing Ph1/1b Study of eganelisib (formerly IPI-549) in combination with nivolumab
Compose a Response to This Article
Other responses
No responses have been published for this article.
